Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review ; volume:20 ; number:1 ; day:26 ; month:5 ; year:2022 ; pages:1-8 ; date:12.2022
World journal of surgical oncology ; 20, Heft 1 (26.5.2022), 1-8, 12.2022
- Creator
-
Mori, Ryota
Uemura, Mamoru
Sekido, Yuki
Hata, Tsuyoshi
Ogino, Takayuki
Takahashi, Hidekazu
Miyoshi, Norikatsu
Mizushima, Tsunekazu
Doki, Yuichiro
Eguchi, Hidetoshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-022-02624-z
- URN
-
urn:nbn:de:101:1-2022072820012826016938
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mori, Ryota
- Uemura, Mamoru
- Sekido, Yuki
- Hata, Tsuyoshi
- Ogino, Takayuki
- Takahashi, Hidekazu
- Miyoshi, Norikatsu
- Mizushima, Tsunekazu
- Doki, Yuichiro
- Eguchi, Hidetoshi
- SpringerLink (Online service)
Other Objects (12)
Thoracoscopic and endoscopic cooperative surgery (TECS): a novel less invasive technique for resection of gastric tube cancer after esophagectomy
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Development and evaluation of a Japanese prediction model for low anterior resection syndrome after rectal cancer surgery
Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer
Development of novel rectal/uterine clamping device
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn’s disease: a case report
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer
Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer
Thoracoscopic and endoscopic cooperative surgery (TECS): a novel less invasive technique for resection of gastric tube cancer after esophagectomy
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Development and evaluation of a Japanese prediction model for low anterior resection syndrome after rectal cancer surgery
Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer
Development of novel rectal/uterine clamping device
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn’s disease: a case report
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer
Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer
Thoracoscopic and endoscopic cooperative surgery (TECS): a novel less invasive technique for resection of gastric tube cancer after esophagectomy
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Development and evaluation of a Japanese prediction model for low anterior resection syndrome after rectal cancer surgery
Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer
Development of novel rectal/uterine clamping device
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn’s disease: a case report
Nivolumab (NSCLC, neoadjuvant) : Addendum zum Projekt A23-74 (Dossierbewertung)
Nivolumab (NSCLC, neoadjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer